JP2002512800A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002512800A5 JP2002512800A5 JP2000546017A JP2000546017A JP2002512800A5 JP 2002512800 A5 JP2002512800 A5 JP 2002512800A5 JP 2000546017 A JP2000546017 A JP 2000546017A JP 2000546017 A JP2000546017 A JP 2000546017A JP 2002512800 A5 JP2002512800 A5 JP 2002512800A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- polynucleotide
- nucleotide sequence
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808866.9A GB9808866D0 (en) | 1998-04-24 | 1998-04-24 | Novel compounds |
| GB9808866.9 | 1998-04-24 | ||
| PCT/EP1999/002766 WO1999055873A2 (en) | 1998-04-24 | 1999-04-20 | Basb006 polynucleotide(s) and polypeptides from neisseria meningitis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010044312A Division JP2010166920A (ja) | 1998-04-24 | 2010-03-01 | 髄膜炎菌由来のｂａｓｂ００６ポリヌクレオチドおよびポリペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002512800A JP2002512800A (ja) | 2002-05-08 |
| JP2002512800A5 true JP2002512800A5 (https=) | 2006-04-27 |
| JP4718009B2 JP4718009B2 (ja) | 2011-07-06 |
Family
ID=10830985
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000546017A Expired - Fee Related JP4718009B2 (ja) | 1998-04-24 | 1999-04-20 | 髄膜炎菌由来のｂａｓｂ００６ポリヌクレオチドおよびポリペプチド |
| JP2010044312A Pending JP2010166920A (ja) | 1998-04-24 | 2010-03-01 | 髄膜炎菌由来のｂａｓｂ００６ポリヌクレオチドおよびポリペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010044312A Pending JP2010166920A (ja) | 1998-04-24 | 2010-03-01 | 髄膜炎菌由来のｂａｓｂ００６ポリヌクレオチドおよびポリペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US6696062B1 (https=) |
| EP (2) | EP1071783A2 (https=) |
| JP (2) | JP4718009B2 (https=) |
| CN (1) | CN1203180C (https=) |
| AU (1) | AU3928499A (https=) |
| CA (1) | CA2326375A1 (https=) |
| GB (1) | GB9808866D0 (https=) |
| WO (1) | WO1999055873A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6914131B1 (en) | 1998-10-09 | 2005-07-05 | Chiron S.R.L. | Neisserial antigens |
| CA2671261A1 (en) * | 1997-11-06 | 1999-05-20 | Novartis Vaccines And Diagnostics S.R.L. | Neisserial antigens |
| GB9808866D0 (en) * | 1998-04-24 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
| NZ515935A (en) | 1999-05-19 | 2004-01-30 | Chiron S | Combination Neisserial compositions and vaccines for the prevention of infections due to Neisseria bacteria such as meningococcal meningitis |
| GB9911683D0 (en) * | 1999-05-19 | 1999-07-21 | Chiron Spa | Antigenic peptides |
| JP2004508801A (ja) | 1999-10-29 | 2004-03-25 | カイロン ソチエタ ア レスポンサビリタ リミタータ | ナイセリア抗原性ペプチド |
| GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
| PT2289545T (pt) | 2000-01-17 | 2016-09-06 | Glaxosmithkline Biologicals Sa | Vacina de omv suplementada contra meningococos |
| NZ521531A (en) * | 2000-02-28 | 2005-12-23 | Chiron S | Heterologous expression of neisserial proteins |
| GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| ATE469915T1 (de) * | 2001-07-27 | 2010-06-15 | Novartis Vaccines & Diagnostic | Antikörper gegen das meningokokken adhäsin app |
| RU2364418C2 (ru) * | 2002-08-02 | 2009-08-20 | ГлаксоСмитКлайн Байолоджикалз с.а. | ВАКЦИННЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ЛИПОПОЛИСАХАРИДЫ ИММУНОТИПА L2 И/ИЛИ L3, ПРОИСХОДЯЩИЕ ИЗ ШТАММА NEISSERIA MENINGITIDIS IgtB- |
| US20060057160A1 (en) * | 2002-08-02 | 2006-03-16 | Ralph Biemans | Vaccine composition |
| HUE031886T2 (en) | 2002-10-11 | 2017-08-28 | Glaxosmithkline Biologicals Sa | Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines |
| EP1667712B1 (en) | 2003-10-02 | 2010-07-21 | GlaxoSmithKline Biologicals S.A. | B. pertussis antigens and use thereof in vaccination |
| US20080280987A1 (en) * | 2006-08-31 | 2008-11-13 | Desai Neil P | Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases |
| UA99659C2 (uk) | 2008-05-30 | 2012-09-10 | Дзе Ю.Ес.Ей., Ес Репрезентед Бай Дзе Секретарі Оф Дзе Армі, Он Бехаф Оф Уолтер Рід Армі | Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування |
| CA2792687A1 (en) | 2010-03-10 | 2011-09-15 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
| WO2011110655A2 (en) | 2010-03-11 | 2011-09-15 | Glaxosmithkline Biologicals S.A. | Vaccine |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| RU2023448C1 (ru) * | 1987-07-30 | 1994-11-30 | Сентро Насьональ Де Биопрепарадос | Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| GB9022190D0 (en) | 1990-10-12 | 1990-11-28 | Perham Richard N | Immunogenic material |
| FR2682041B1 (fr) | 1991-10-03 | 1994-01-14 | Pasteur Merieux Serums Vaccins | Vaccin contre les infections a neisseria meningitidis. |
| CA2138997C (en) | 1992-06-25 | 2003-06-03 | Jean-Paul Prieels | Vaccine composition containing adjuvants |
| US5776468A (en) | 1993-03-23 | 1998-07-07 | Smithkline Beecham Biologicals (S.A.) | Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A |
| JPH08511000A (ja) | 1993-04-06 | 1996-11-19 | フレッド ハッチンソン キャンサー リサーチ センター | リンパ球におけるキメラサイトカインレセプター |
| CA2164623A1 (en) | 1993-06-07 | 1994-12-22 | Robert Enrico Pacifici | Hybrid receptor molecules |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| EP1167379A3 (en) | 1994-07-15 | 2004-09-08 | University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| US6245337B1 (en) * | 1994-08-25 | 2001-06-12 | Washington University | Haemophilus adherence and penetration proteins |
| US6121037A (en) * | 1994-10-18 | 2000-09-19 | Stojiljkovic; Igor | Bacterial hemoglobin receptor genes |
| US6265567B1 (en) * | 1995-04-07 | 2001-07-24 | University Of North Carolina At Chapel Hill | Isolated FrpB nucleic acid molecule |
| WO1996033276A1 (en) | 1995-04-21 | 1996-10-24 | Human Genome Sciences, Inc. | NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| CU22559A1 (es) | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
| ES2166097T5 (es) * | 1996-08-27 | 2007-03-16 | Novartis Vaccines And Diagnostics, Inc. | Glicoconjugados de neisseria meningitidis de serogrupo b y procedimientos para usarlos. |
| US6914131B1 (en) * | 1998-10-09 | 2005-07-05 | Chiron S.R.L. | Neisserial antigens |
| CA2671261A1 (en) * | 1997-11-06 | 1999-05-20 | Novartis Vaccines And Diagnostics S.R.L. | Neisserial antigens |
| GB9808734D0 (en) * | 1998-04-23 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
| GB9808866D0 (en) * | 1998-04-24 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
| EP1163343B1 (en) * | 1999-03-12 | 2009-12-09 | GlaxoSmithKline Biologicals S.A. | Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| GB0025171D0 (en) * | 2000-10-13 | 2000-11-29 | Smithkline Beecham Biolog | Novel compounds |
| ATE469915T1 (de) * | 2001-07-27 | 2010-06-15 | Novartis Vaccines & Diagnostic | Antikörper gegen das meningokokken adhäsin app |
-
1998
- 1998-04-24 GB GBGB9808866.9A patent/GB9808866D0/en not_active Ceased
-
1999
- 1999-04-20 CA CA002326375A patent/CA2326375A1/en not_active Abandoned
- 1999-04-20 CN CNB998077712A patent/CN1203180C/zh not_active Expired - Fee Related
- 1999-04-20 WO PCT/EP1999/002766 patent/WO1999055873A2/en not_active Ceased
- 1999-04-20 AU AU39284/99A patent/AU3928499A/en not_active Abandoned
- 1999-04-20 EP EP99922122A patent/EP1071783A2/en not_active Withdrawn
- 1999-04-20 US US09/673,896 patent/US6696062B1/en not_active Expired - Fee Related
- 1999-04-20 JP JP2000546017A patent/JP4718009B2/ja not_active Expired - Fee Related
- 1999-04-20 EP EP10011715A patent/EP2360260A1/en not_active Withdrawn
-
2003
- 2003-12-19 US US10/742,345 patent/US7419824B2/en not_active Expired - Fee Related
-
2008
- 2008-07-25 US US12/180,055 patent/US20100196409A1/en not_active Abandoned
-
2010
- 2010-03-01 JP JP2010044312A patent/JP2010166920A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002512800A5 (https=) | ||
| JP2693145B2 (ja) | 乳頭腫ウイルス型特異的抗体 | |
| Svehag et al. | THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY: II. 19S and 7S Antibody Formation: Differences in Antigen Dose Requirement for Sustained Synthesis, Anamnesis, and Sensitivity to X-Irradiation | |
| JP2010166921A5 (https=) | ||
| KR860700090A (ko) | 어드헤신(Adhesin)항원 | |
| JPS61289888A (ja) | ワクシニアｄｎａ | |
| RU99122686A (ru) | Модифицированные молекулы фно альфа, днк, кодирующие эти модифицированные молекулы фно альфа, и вакцины, включающие эти модифицированные молекулы фно альфа и днк | |
| CN86102858A (zh) | 制备猪支原体的重组表面抗原及其疫苗的方法 | |
| JP4173549B2 (ja) | コアグラーゼ陰性ブドウ球菌に由来する、新規フィブリノーゲン結合たん白質 | |
| US20090074781A1 (en) | Dengue virus peptide vaccine and methods of preparing and using the same | |
| CA2217522A1 (en) | Isolated frpb nucleic acid molecule and vaccine | |
| CN113186223A (zh) | 一种新冠病毒疫苗的表达载体及其构建方法、应用和疫苗 | |
| JP4820489B2 (ja) | ヒト型結核菌により発現され且つｂｃｇによって発現されないタンパク質、ならびに診断薬およびワクチンとしてのそれらの使用 | |
| CN116970058B (zh) | 针对tp53基因r249s突变的肿瘤新抗原多肽及其应用 | |
| JPH06503559A (ja) | サブユニット・パピローマウイルス・ワクチンおよびそれに使用するペプチド | |
| JPH05501401A (ja) | 組換え微生物との転移増殖によるワクチン又はトキソイド製剤及び免疫の方法 | |
| KR101845571B1 (ko) | 전통적 돼지열에 대한 마커 백신 | |
| JP2003533990A (ja) | 百日咳菌、パラ百日咳菌および気管支敗血症菌のペルタクチンの繰返し領域の多型性を有するポリペプチド、ならびに診断および免疫原性組成物におけるその使用 | |
| JPH08510714A (ja) | エプスタイン−バーウィルスからの免疫反応性ペプチド | |
| CN111138553B (zh) | 一种融合蛋白及一种弓形虫亚单位疫苗及其疫苗组合物 | |
| CN117024522A (zh) | 针对pik3ca基因e545k突变的肿瘤新抗原多肽及其应用 | |
| DE60025522T2 (de) | Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung | |
| JP2003503059A (ja) | 破傷風毒素ポリペプチド | |
| NZ520600A (en) | Novel therapeutic compositions for treating infection by Lawsonia spp | |
| CN115850377A (zh) | 基于nras基因q61k突变的肿瘤新抗原多肽及其应用 |